ICER releases draft evidence report on treatments for Duchenne muscular dystrophy

22 May 2019 - Public comment period now open until June 18, 2019; requests to make oral comment during public ...

Read more →

Extending VBP models into Medicaid drug purchasing: challenges and opportunities

22 May 2019 - Over the past decade, both public and private payers have increasingly sought to develop payment policies that ...

Read more →

HHS marches forward to enhance drug price transparency

21 May 2019 - HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to ...

Read more →

Agile Therapeutics announces FDA acceptance of the NDA resubmission of Twirla

22 May 2019 - FDA assigns Prescription Drug User Fee Act goal date of 16 November 2019. ...

Read more →

FDA approves Sorilux for adolescent plaque psoriasis

22 May 2019 - Mayne Pharma is pleased to announce that the US FDA has approved Sorilux (calcipotriene) foam, 0.005% ...

Read more →

House Committee proposes 6% increase in FDA funding for FY 2020

22 May 2019 - The House Appropriations Committee on Wednesday released a draft fiscal year 2020 funding bill for the ...

Read more →

U.S. FDA grants priority review of Invokana (canagliflozin) sNDA for the treatment of chronic kidney disease in patients with type 2 diabetes

22 May 2019 - Application was submitted in March 2019 based on landmark phase 3 CREDENCE renal outcomes study published in ...

Read more →

Lilly selling half-price version of popular Humalog insulin

22 May 2019 - A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in ...

Read more →

Free market activists slam Trump's international drug pricing index

21 May 2019 - Rep. Andy Biggs: 'Seems to me like we're importing drug controls'. ...

Read more →

PolyPid receives a second QIDP designation for D-PLEX100 in abdominal surgery

21 May 2019 - PolyPid Ltd announced today that the United States FDA has granted a second qualified infectious disease product ...

Read more →

Louisiana is creating a drug price revolution

20 May 2019 - Louisiana is putting the final touches on a revolutionary deal that promises to simultaneously control health ...

Read more →

FDA replaces withdrawn biosimilar guidance with new one on quality-related considerations

21 May 2019 - A week after finalizing guidance on developing interchangeable biosimilars, the US FDA has drafted guidance for ...

Read more →

Novartis CEO: gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model

17 May 2019 - We live in an incredible era of progress in human health. Advances in cell and gene ...

Read more →

Google sister company Verily is teaming with big pharma on clinical trials

21 May 2019 - Pharma companies are looking to work with Verily, which is part of the Alphabet umbrella, as they ...

Read more →

Could drug price transparency raise prices? These lobbyists and lawmakers think so.

21 May 2019 - Objections made on disclosing rebates and revealing data about free samples. ...

Read more →